A comprehensive view of Biopharmaceuticals / Biologics. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Government & Public Policy Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

Shah Capital Withdraws Proxy Campaign Against Re-Election of Directors at Novavax’s 2024 Annual Meeting
Published: May 20, 2024 by GlobeNewswire
Regeneron Pharmaceuticals Inc Files Patent Application for Stabilized Formulations Containing Anti-MUC16 X Anti-CD3 Bispecific Antibodies
Published: May 20, 2024 by Indian Patents News
Regeneron Pharmaceuticals Submits Patent Application for Anti-FGFR3 Antibodies and Antigen-Binding Fragments and Methods of Use Thereof
Published: May 19, 2024 by Pharmaceutical Patent News
INTERNATIONAL PATENT: KANEKA CORPORATION, 株式会社カネカ, RIKEN, 国立研究開発法人理化学研究所 FILES APPLICATION FOR "METHOD FOR PRODUCING PLURIPOTENT STEM CELLS AND METHOD FOR INDUCING DIFFERENTIATION OF PLURIPOTENT STEM CELLS"
Published: May 19, 2024 by U.S. Fed News
INTERNATIONAL PATENT: F. HOFFMANN-LA ROCHE AG, HOFFMANN-LA ROCHE INC. FILES APPLICATION FOR "ANTIBODIES BINDING TO HLA-A*02/FOXP3"
Published: May 19, 2024 by U.S. Fed News

Ask us about our Government & Public Policy market view

Trending Chart

Interactive chart with headline count